Endolabas - Company finances
|
EUR
|
2019
From: 2019-08-06
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 650 | 60,165 | 98,956 | 130,646 | 170,122 | 145,662 | 258,167 |
| Profit before tax | - | - | - | - | - | - | - |
| Net profit | -17,496 | 31,584 | 41,497 | 31,027 | 46,852 | -4,936 | 36,421 |
| Equity | -14,996 | 16,588 | 58,085 | 89,112 | 88,906 | 83,969 | 92,391 |
| Liabilities | 15,646 | 2,976 | 2,931 | 5,684 | 40,023 | 25,495 | 26,939 |
| Non-current assets | 0 | 6,064 | 18,953 | 39,478 | 69,732 | 67,111 | 65,492 |
| Current assets | 650 | 13,640 | 42,281 | 57,961 | 57,808 | 41,122 | 52,467 |
| Total assets | 650 | 19,704 | 61,234 | 97,439 | 127,540 | 108,233 | 117,959 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 36,013 | 33,832 | 48,046 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +9156.2% | +64.5% | +32.0% | +30.2% | -14.4% | +77.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2691.7% | 160.3% | 67.8% | 31.8% | 36.7% | -4.6% | 30.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 190.4% | 71.4% | 34.8% | 52.7% | -5.9% | 39.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2691.7% | 52.5% | 41.9% | 23.7% | 27.5% | -3.4% | 14.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.1 | 0.1 | 0.5 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 650 | 60,165 | 98,956 | 130,646 | 92,796 | 72,831 | 193,630 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Endolabas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-16 | 2024-05-19 | 3.74 |
| 2023-06-16 | 2023-06-19 | 3.12 |
Endolabas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-24 | 2026-01-24 | 7.58 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Endolabas, UAB (code 305223921) is a private limited liability company operating in repair and maintenance of electronic and optical equipment. In the latest financial year 2025, the company generated revenue of €258.2K and net profit of €36.4K, corresponding to a profit margin of 14.1%. Revenue increased by 77.2% year on year and by 51.8% over two years, showing a strong rebound after 2024. The 2024 result was a net loss of €4.9K on revenue of €145.7K, while 2023 ended with net profit of €46.9K on revenue of €170.1K. At year-end 2025, total assets stood at €118.0K, equity at €92.4K and liabilities at €26.9K. The company therefore had a high equity ratio of 78.3% and a debt-to-equity ratio of 0.29. Asset turnover reached 2.19x, while ROE was 39.4% and ROA 30.9%. Revenue per employee was €258.2K and profit per employee €36.4K.